Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Long Term Debt
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed N.V (MYNZ) Other Accumulated Expenses: 2021-2023

  • Mainz Biomed N.V's Other Accumulated Expenses was N/A to $2,149 in Q1 2023 from the same period last year, while for Mar 2023 it was $2,149, marking a year-over-year change of. This contributed to the annual value of $3,248 for FY2022, which is 482.08% up from last year.
  • As of Q1 2023, Mainz Biomed N.V's Other Accumulated Expenses stood at $2,149, which was down 33.84% from $3,248 recorded in Q4 2022.
  • In the past 5 years, Mainz Biomed N.V's Other Accumulated Expenses registered a high of $3,248 during Q4 2022, and its lowest value of $558 during Q4 2021.
  • For the 3-year period, Mainz Biomed N.V's Other Accumulated Expenses averaged around $2,036, with its median value being $2,170 (2022).
  • Data for Mainz Biomed N.V's Other Accumulated Expenses shows a peak YoY surged of 482.08% (in 2022) over the last 5 years.
  • Quarterly analysis of 3 years shows Mainz Biomed N.V's Other Accumulated Expenses stood at $558 in 2021, then surged by 482.08% to $3,248 in 2022, then reached $2,149 in 2023.
  • Its Other Accumulated Expenses was $2,149 in Q1 2023, compared to $3,248 in Q4 2022 and $2,190 in Q2 2022.